Pini Ben-Elazar
Fortune : 262 479 $ au 31/08/2026
Fortune : 262 479 $ au 31/08/2026
Pini Ben-Elazar is the founder of Bio-Gal.
Current jobs include Chief Executive Officer at Mor Research Applications Ltd., Director at Enox Biopharma, Inc., and Independent Director at Regentis Biomaterials Ltd. starting in 2026.
Former jobs include Chairman & Chief Executive Officer at Mor Research Applications Ltd., Director at Deliverance Ltd. (Israel), Director at Beyond Air Ltd., and Director at Claritas Pharmaceuticals, Inc. in 2017.
Education includes an MBA from Johnson & Wales University, Inc.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/07/2026 | 128 666 ( 1,83 % ) | 262 479 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| REGENTIS BIOMATERIALS LTD. | Directeur/Membre du Conseil | 24/02/2026 |
Enox Biopharma, Inc.
Enox Biopharma, Inc. Medical SpecialtiesHealth Technology Develops antimicrobial medical devices coated with Nitric Oxide | Directeur/Membre du Conseil | - |
Mor Research Applications Ltd.
Mor Research Applications Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business services | Directeur Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
| CLARITAS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 10/10/2017 |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Operates as a clinical-stage medical device and biopharmaceutical company | Directeur/Membre du Conseil | - |
Bio-Gal
Bio-Gal Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for Multiple Myeloma patients | Fondateur | - |
Mor Research Applications Ltd.
Mor Research Applications Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business services | Président | - |
Deliverance Ltd. (Israel)
Deliverance Ltd. (Israel) Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices | Président | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Enox Biopharma, Inc.
Enox Biopharma, Inc. Medical SpecialtiesHealth Technology Develops antimicrobial medical devices coated with Nitric Oxide | Health Technology |
Johnson & Wales University, Inc.
Johnson & Wales University, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regentis Biomaterials Ltd.
Regentis Biomaterials Ltd. BiotechnologyHealth Technology Develops proprietary hydrogels for tissue regeneration | Health Technology |
Mor Research Applications Ltd.
Mor Research Applications Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business services | Commercial Services |
Deliverance Ltd. (Israel)
Deliverance Ltd. (Israel) Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices | Health Technology |
Bio-Gal
Bio-Gal Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for Multiple Myeloma patients | Health Technology |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Operates as a clinical-stage medical device and biopharmaceutical company | Health Technology |
Claritas Pharmaceuticals, Inc.
Claritas Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops and commercializes therapies for patients | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national